Company Background

CluePoints is focused on developing advanced software to enable the highest quality clinical research. It's not an abstract concept; it's our daily commitment.

Our team of experts, specializing in Risk-Based Quality Management (RBQM), is at the forefront of this transformative journey.

At the core of this evolution, we are turning artificial intelligence into a force for human intelligence and it’s not just a slogan; it’s the essence of the CluePoints’ brand. Our RBQM innovators, implementing the latest developments in advanced statistics and machine learning, are developing AI-powered solutions that go beyond data points and algorithms. They are building enterprise software solutions to power smarter clinical trials.

Markets Served

CluePoints work with a broad range of organizations across different sectors including, pharmaceuticals, CROs, medical devices and the academic community, providing a best-in-class platform of solutions to aid in the development of innovative therapies to improve people’s lives globally.

Products

Services/Capabilities

The CluePoints’ platform of solutions offers a better way of identifying, visualizing, managing, and documenting trial risks that could compromise patient safety and delay the approval of Investigational Products.

Underpinned by Central Statistical Monitoring, a technique that’s currently being used by the Food and Drug Administration (FDA) for selecting sites for inspection, our cloud-based products are deployed to support traditional onsite monitoring, medical review, and quality to drive a Risk-Based Approach to Study Execution (RBx) and ultimately, to achieve ICH E6 (R2) compliance.

We are empowering improved human outcomes accelerated by AI-powered insights and allowing the Life Science industry to focus on what matters most.